On 13 December 2021, the Office of United States Trade Representative (USTR) posted the following request for public comment in relation to its 2022 Special 301 Review: Identification of Countries Under Section 182 of the Trade Act of 1974 noting… Continue Reading
On 1 December 2021, the special session of the World Health Assembly adopted a decision launch intergovernmental negotiations to draft and negotiate a WHO convention,agreement or other international instrument on pandemic prevention, preparedness and response; this signaled the intent of… Continue Reading
On Saturday, 29 January 2022,Knowledge Ecology International (KEI) delivered the following statement on the Global strategy and plan of action on public health, innovation and intellectual property at the 150th session of the World Health Organization’s Executive Board. Access to… Continue Reading
On Wednesday, 26 January 2022, Knowledge Ecology International (KEI) delivered the following statement on a possible pandemic treaty at the 150th session of the World Health Organization’s Executive Board. The WHO negotiations on a pandemic treaty are not a quick… Continue Reading
Update on Patent-Related Measures in Germany in View of Corona Pandemic Thomas Musmann (Rospatt Osten Pross)/April 2, 2020 Update on Patent-Related Measures in Germany in View of Corona Pandemic German Government Plans Possibilities to Limit Patents In View of Corona… Continue Reading
Draft This is work in progress, and is part of a larger project on timelines. This particular timeline is unfinished, and may contain errors. Timeline of privileged regarding the commercialization and use of knowledge Timeline collection: Part 1: before 1980,… Continue Reading
On Wednesday, 8 December 2021, Knowledge Ecology International (KEI) delivered the following statement on patents and health at the 33rd session of the WIPO Standing Committee on the Law of Patents (SCP). 8 December 2021 We take note of WIPO’s… Continue Reading
On Monday, 6 December 2021, India delivered an opening statement on behalf of the Asia and Pacific Group (AGP). The Islamic Republic of Iran, Bangladesh, Singapore, Indonesia, United Arab Emirates, and the Republic of Korea are just a few of… Continue Reading
On Friday, December 3, 2021, KEI requested an open public interest license to allow the exploitation of PF-07321332 (marketed in combination with ritonavir under the brand Paxlovid) in the Dominican Republic. PF-07321332, being developed by Pfizer, has shown promising results… Continue Reading